Medinotec FY2026: Revenue $9.73M, EPS $0.07
Medinotec FY2026 Financial Results
Medinotec Inc. reported fiscal 2026 revenue of $9.73 million and net income of $794.5K, with diluted earnings per share (EPS) of $0.07. Revenue rose 7% year over year, while net income and EPS declined.
Financial Highlights
Revenue: $9.73M (prior year: $9.11M, +7%). Net income: $794.5K (prior year: $2.16M, -63.2%). Diluted EPS: $0.07 (prior year: $0.18, -61.1%).
Business Highlights
Growth was driven by stronger international sales, notably from distribution in South Africa. The company shifted toward distribution agreements outside the U.S. Medinotec secured FDA 510(k) clearance for Trachealator and plans a U.S. launch of OutFlo. Selling costs increased to support global market penetration.
The news, analyses, and comments on this platform do not constitute investment advice. When making investment decisions, you should conduct your own research and consult with a qualified financial advisor if necessary. FiNews cannot be held responsible for any losses that may arise from the use of this information.
More Headlines
Tokyo Core Inflation Slows, Remains Below BOJ Target
Tokyo Core Inflation Slows, Remains Below BOJ Target
…Nikkei May Rise on Hopes for U.S.-Iran Peace Deal
Nikkei May Rise on Hopes for U.S.-Iran Peace Deal
…Australian Pension Fund HUB24 Faces Regulatory Scrutiny
Australian Pension Fund HUB24 Faces Regulatory Scrutiny
…